Clinical trials
Completed Observational Latent Tuberculosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Oxford University Clinical Research Unit, Vietnam | 2 |
| Tuberculosis Network European Trialsgroup | 2 |
| University Hospital, Geneva | 2 |
| Asan Medical Center | 1 |
| BioMérieux | 1 |
| Case Western Reserve University | 1 |
| Centers for Disease Control and Prevention | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre for Infectious Disease Research in Zambia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Latent Tuberculosis | 31 |
| Tuberculosis | 13 |
| Tuberculosis Disease | 6 |
| HIV Infections | 4 |
| Kidney Failure, Chronic | 2 |
| Tuberculosis, Multidrug-Resistant | 2 |
| Tuberculosis, Pulmonary | 2 |
| COVID-19 | 1 |
| Collagen Diseases | 1 |
| Extensively Drug-Resistant Tuberculosis | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.